WKRC-Local News 12: UC researchers develop antibody to neutralize cocaine high
UC scientist makes advances in treating addiction
Local 12 News journalist Angenette Levy spoke with Andrew Norman, professor in the UC Department of Pharmacy and Systems Physiology, for a segment about his latest research. Norman leads a team of researchers at UC College of Medicine, who have developed an anti-cocaine antibody for humans that may help block the effects of cocaine and aid individuals battling drug addiction to stay in recovery.
The human antibody, reengineered in a laboratory, is now being manufactured for human trials that are expected to begin later this year. When injected into the bloodstream, that antibody attaches to cocaine, preventing it from entering the brain and limiting its behavioral effects. Its success at reducing the drug’s effects have been documented in animal models of cocaine relapse.
Norman said the antibody isn’t a silver bullet, but possibly another tool in the toolbox for battling addiction. He spoke to Levy along with collaborator Terry Kirley, also a professor in the UC Department of Pharmacy and Systems Physiology.
Listen to the full segment on WKRC-Local 12 News.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
University of Cincinnati graduate programs rise in national rankings across high-demand fields
May 13, 2026
University of Cincinnati graduate programs climbed in the latest U.S. News & World Report rankings, led by strong gains in workforce-focused fields including public health, clinical psychology and business.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.